48 results on '"Veszeli, Nóra"'
Search Results
2. Clinical Characteristics and Safety of Plasma-Derived C1-Inhibitor Therapy in Children and Adolescents with Hereditary Angioedema—A Long-Term Survey
3. International Consensus on the Use of Genetics in the Management of Hereditary Angioedema
4. Idiopathic Nonhistaminergic Acquired Angioedema Versus Hereditary Angioedema
5. Thyroid hormones and complement parameters in hereditary angioedema with C1-inhibitor deficiency
6. Serum fetuin-A, tumor necrosis factor alpha and C-reactive protein concentrations in patients with hereditary angioedema with C1-inhibitor deficiency
7. Complement genetic variants and FH desialylation in S. pneumoniae-Haemolytic Uraemic Syndrome
8. “Nuts and Bolts” of Laboratory Evaluation of Angioedema
9. The relationship between anxiety and quality of life in children with hereditary angioedema
10. The role of the complement system in hereditary angioedema
11. International consensus on the diagnosis and management of pediatric patients with hereditary angioedema with C1 inhibitor deficiency
12. FHR-5 Serum Levels and CFHR5 Genetic Variations in Patients With Immune Complex-Mediated Membranoproliferative Glomerulonephritis and C3-Glomerulopathy
13. A Novel Homozygous In-Frame Deletion in Complement Factor 3 Underlies Early-Onset Autosomal Recessive Atypical Hemolytic Uremic Syndrome - Case Report
14. Complement Genetic Variants and FH Desialylation in S. pneumoniae-Haemolytic Uraemic Syndrome
15. Patterns of C1-Inhibitor/Plasma Serine Protease Complexes in Healthy Humans and in Hereditary Angioedema Patients
16. Validation of Early Increase in Complement Activation Marker sC5b-9 as a Predictive Biomarker for the Development of Thrombotic Microangiopathy After Stem Cell Transplantation
17. CFHR5 Genetic Variations and Serum Levels in Patients with Immune-Complex-Mediated Membranoproliferative Glomerulonephritis and C3-Glomerulopathy
18. Patterns of C1-Inhibitor/Plasma Serine Protease Complexes in Healthy Humans and in Hereditary Angioedema Patients
19. Changes of coagulation parameters during erythema marginatum in patients with hereditary angioedema
20. Evaluation of the efficacy and safety of home treatment with the recombinant human C1-inhibitor in hereditary angioedema resulting from C1-inhibitor deficiency
21. Hereditary angioedema attack: what happens to vasoactive mediators?
22. Plazmaenzimrendszerek és neutrofil granulociták vizsgálata C1-inhibitor hiányában kialakuló herediter angioödémában
23. A D3-vitamin-szint és a betegség súlyossága közötti kapcsolat vizsgálata herediter angioödémában
24. Parallel determination of human plasma serine proteases complexed with C1-inhibitor
25. Secreted Phospholipases A2 in Hereditary Angioedema With C1-Inhibitor Deficiency
26. Home treatment with conestat alfa in attacks of hereditary angioedema due to C1-inhibitor deficiency
27. A novel prophylaxis with C1-inhibitor concentrate in hereditary angioedema during erythema marginatum
28. A danazolkezelés hatása C1-inhibitor-hiány okozta hereditaer angiooedemás gyermekek növekedésére
29. Health-related quality of life among children with hereditary angioedema
30. Glucocorticoid receptor gene polymorphisms in hereditary angioedema with C1-inhibitor deficiency
31. The very first kinetic follow-up of a single edematous attack of a C1-INH-HAE patient: Classical pathway components in focus
32. First report of icatibant treatment in a pregnant patient with hereditary angioedema
33. Risk of thromboembolism in patients with hereditary angioedema treated with plasma-derived C1-inhibitor
34. The effect of long-term danazol treatment on haematological parameters in hereditary angioedema
35. Neutrophil activation during attacks in patients with hereditary angioedema due to C1-inhibitor deficiency
36. Secreted Phospholipases A2 in Hereditary Angioedema With C1-Inhibitor Deficiency.
37. Comprehensive study into the activation of the plasma enzyme systems during attacks of hereditary angioedema due to C1-inhibitor deficiency
38. Frequency of the virilising effects of attenuated androgens reported by women with hereditary angioedema
39. Home treatment of attacks with conestat alfa in hereditary angioedema due to C1-inhibitor deficiency
40. A systematic analysis of the complement pathways in patients with neuromyelitis optica indicates alteration but no activation during remission
41. Complement levels and complement activation in neuromyelitis optica
42. Plasma-Derived C1 Inhibitor Concentrate Did Not Increase the Risk of Thromboembolism in Patients with Hereditary Angioedema Due to C1-Inhibitor Deficiency – a Long-Term Survey
43. Successful prophylaxis with recombinant human C1 inhibitor in a patient with hereditary angioedema
44. Complement Genetic Variants and FH Desialylation in S. pneumoniae-Haemolytic Uraemic Syndrome
45. Secreted Phospholipases A2 in Hereditary Angioedema With C1-Inhibitor Deficiency
46. [Analysis of the relationship between vitamin D 3 level and disease severity in hereditary angioedema].
47. Secreted Phospholipases A 2 in Hereditary Angioedema With C1-Inhibitor Deficiency.
48. [Effect of danazol treatment on growth in pediatric patients with hereditary angioedema due to C1-inhibitor deficiency].
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.